Impact of a remote monitoring program on all-cause mortality of patients with heart failure: National, real-world evidence of the TELESAT study

11 May 2024 (08:54 - 09:02)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Professor Nicolas Girerd

University Hospital of Nancy, Nancy (France)

9 More presentations in this session

Presentation thumbnail

Timing of Cardio-Kidney Protection with SGLT2 Inhibitors: Insights from Four Large-scale Placebo-Controlled Outcome Trials

Doctor M. Vaduganathan (Boston, US)

Presentation thumbnail

Discussant review - CANVAS Program, CREDENCE, DAPA-HF, and DELIVER

Professor M. Packer (Dallas, US)

Presentation thumbnail

Intravenous iron therapy with ferric carboxymaltose results in a rapid and sustained rise in myocardial iron content through a non-canonical pathway: a translational study

Professor S. Lakhal-Littleton (Oxford, GB)

Presentation thumbnail

Discussant review - IV iron and the heart

Professor E. Jankowska (Wroclaw, PL)

Presentation thumbnail

Discussant review - TELESAT

Doctor M. Costanzo (Naperville, US)

Access the full session

Session thumbnail

Late breaking clinical trials I

The Event

Event poster

Heart Failure 2024

11 May 2024 08:54 CET

You may be interested in

Congress Presentation

Accessible by design: how TELESAT-HF brings connected care to every heart

Congress Presentation

Reduction on all-cause mortality with a remote monitoring program in heart failure: results of the TELESAT-HF study

Congress Presentation

TELESAT-HF study: reduction of all-cause mortality in heart failure patients with a previous hospitalization in a real life study using a patient centered remote monitoring device

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources